In recent trading session, MetLife, Inc. (NYSE:MET) saw 1,733,509 shares changing hands with its beta currently measuring 1.3. Company’s recent per share price level of $39.6 trading at $0.47 or 1.2% at recent trade assigns it a market valuation of $36.07 Billion. That current trading price of MET’s stock is at a discount of -34.55% from its 52-week high price of $53.28 and is indicating a premium of 42.3% from its 52-week low price of $22.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.22 Million shares which gives us an average trading volume of 5.33 Million if we extend that period to 3-months.

For MetLife, Inc. (MET), analysts’ consensus is at an average recommendation of Overweight while assigning it a mean rating of 2.2. Splitting up the data highlights that, out of 13 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. 5 suggested the stock as a Hold whereas 8 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $1.64 in the current quarter.

MetLife, Inc. (NYSE:MET) trade information

Upright in the green today for gaining 1.2%, in the last five days MET remained trading in the green while hitting it’s week-highest on Monday, Oct 12 when the stock touched $40.42- price level, adding 2.44% to its value on the day. MetLife, Inc.’s shares saw a change of -22.64% in year-to-date performance and have moved -0.13% in past 5-day. MetLife, Inc. (NYSE:MET) showed a performance of 4.78% in past 30-days. Number of shares sold short was 10.54 Million shares which calculate 1.98 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $45.8 to the stock, which implies a rise of 15.66% to its current value. Analysts have been projecting $39 as a low price target for the stock while placing it at a high target of $59. It follows that stock’s current price would jump +48.99% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1.52% for stock’s current value.

MetLife, Inc. (MET) estimates and forecasts

Statistics highlight that MetLife, Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company added +18.36% of value to its shares in past 6 months, showing an annual growth rate of -7.86% while that of industry is -8.8. Apart from that, the company came raising its revenue forecast for fiscal year 2020. The company is estimating its revenue growth to increase by 29.1% in the current quarter and calculating -24.7% decline in the next quarter. This year revenue growth is estimated to drop -7.5% from the last financial year’s standing.

4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $16Billion for the same. And 4 analysts are in estimates of company making revenue of $16.02 Billion in the next quarter that will end in December 01, 2020. Company posted $16.92 Billion and $18.15 Billion of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to drop by -5.4% while estimating it to be -11.7% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 2.3% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 23.3% while estimates for its earnings growth in next 5 years are of 3.31%

MET Dividends

MetLife, Inc. is more likely to be releasing its next quarterly report between November 04 and November 04, 2020, and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 4.7%, the share has a forward dividend of 1.84 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 3.59%.

MetLife, Inc. (NYSE:MET)’s Major holders

Insiders are in possession of 15.54% of company’s total shares while institution are holding 77.43% percent of that, with stock having share float percentage of 91.68%. Investors also watch the number of corporate investors in a company very closely, which is 1423 institutions for MetLife, Inc. that are currently holding shares of the company. Blackrock Inc. is the top institutional holder at MET for having 69.96 Million shares of worth $2.55 Billion. And as of June 29, 2020, it was holding 7.71% of the company’s outstanding shares.

The second largest institutional holder is Dodge & Cox Inc, which was holding about 66.34 Million shares on June 29, 2020. The number of shares represents firm’s hold over 7.31% of outstanding shares, having a total worth of $2.42 Billion.

On the other hand, Dodge & Cox Stock Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of June 29, 2020, the former fund manager was holding 41898800 shares of worth $1.53 Billion or 4.62% of the total outstanding shares. The later fund manager was in possession of 19.36 Million shares on June 29, 2020, making its stake of worth around $707.1 Million in the company or a holder of 2.13% of company’s stock.